Acquired resistance to PD1 inhibition in melanoma [ 2017 - 2020 ]

Research Grant

[Cite as]

Researchers: Prof Helen Rizos (Principal investigator) ,  Dr Alexander Menzies Dr Matteo Carlino Prof Richard Kefford Prof Xu Dong Zhang

Brief description New drugs targeting the immune system have dramatically improved the survival of melanoma patients. Nevertheless, 30-40% of patients responding to these new inhibitor will develop drug resistance. This project utilizes patient tumour samples to examine the mechanisms of acquired resistance to immune checkpoint inhibitors. This information will accelerate the identification of novel combination therapies to improve patient outcomes.

Funding Amount $AUD 1,011,136.55

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]